linsidomine has been researched along with Cell Transformation, Neoplastic in 1 studies
linsidomine: RN given refers to parent cpd; structure
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takabe, W | 1 |
| Niki, E | 1 |
| Uchida, K | 1 |
| Yamada, S | 1 |
| Satoh, K | 1 |
| Noguchi, N | 1 |
1 other study available for linsidomine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Oxidative stress promotes the development of transformation: involvement of a potent mutagenic lipid peroxidation product, acrolein.
Topics: Acrolein; Amidines; Animals; Antioxidants; Benzo(a)pyrene; Biotransformation; Cell Transformation, N | 2001 |